GlobeNewswire by notified

Verisk Launches Solution for Insurers to Assess Underwriting Models and Variables for Unfair Discrimination


Fairness-as-a-service solution helps insurers address potential regulatory testing requirements

JERSEY CITY, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Insurers now have a proven method to help assess their pricing models for unfair discrimination against certain protected classes, like race. Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, today announced the launch of FairCheck, a solution designed to help insurers test their personal lines models and variables to respond to regulatory changes. FairCheck comprises a customizable, scalable methodology and consultative service to help evaluate and mitigate the potential for unfairly discriminatory outcomes, including in advance of regulatory filings.

As the use of predictive models and similar automated tools increases, coupled with a heightened focus on diversity, equity and inclusion, there has been enhanced regulatory scrutiny around the effectiveness of modern techniques to safeguard against unfairly discriminatory outcomes. Verisk’s solution can help insurers respond to these developments and meet their unique needs in different states.

“We took a proactive approach in assessing our own personal auto rating model to determine whether there were unfair pricing differentials regarding race,” said Adrian Cuc, senior vice president of analytics at Verisk. “We discovered that race was not a contributing factor in our model. The analysis serves as a foundation for our FairCheck solution that is customizable to assess individual insurer models, different variables within their models and various geographical regions for potential unintended bias. It is a meaningful step in measuring and understanding what impact, if any, race may play in insurer pricing models. By understanding its potential impact, an insurer can determine whether they need to begin to evaluate and mitigate the potential for unfairly discriminatory outcomes.”

Verisk has longstanding historical practices and protocols to protect against unfair discrimination related to the ratemaking process, while supporting actuarially sound, cost-based pricing. With one of the largest insurance databases, it was able to test and develop a methodology to effectively investigate the role of race in personal lines pricing models and variables and quantify its contribution to loss costs. The results of the analysis were published in the white paper, “Assessing for Unfair Discrimination with Respect to Race in a Personal Rating Model.”

Verisk’s methodology was reviewed by the Maguire Academy of Insurance and Risk Management in the Haub School of Business of Saint Joseph’s University.

“It is quite obvious that Verisk put much thought into the process for this study,” said Michael Angelina, executive in residence of the Maguire Academy of Insurance and Risk Management. “As Verisk is taking a leading role in this equity in insurance initiative, getting the approach correct is imperative, and I believe that they have developed a robust process.” 

With its proven methodology and team of experts in government relations, actuarial science, data science and analytics, Verisk is equipped to help support impartial underwriting and rating outcomes that benefit insurers, regulators and consumers alike.

“Our team took a rigorous and objective approach to analyzing and developing a methodology that helps ensure equitable insurance offerings for all,” said Neil Spector, president of Underwriting Solutions at Verisk. “The insurance regulatory landscape is constantly evolving, and with our vast data and leading compliance and regulatory services, we’re uniquely positioned to help the industry adapt and respond to changes.”

About Verisk 
Verisk (Nasdaq: VRSK) is a leading strategic data analytics and technology partner to the global insurance industry. It empowers clients to strengthen operating efficiency, improve underwriting and claims outcomes, combat fraud and make informed decisions about global risks, including climate change, extreme events, ESG and political issues. Through advanced data analytics, software, scientific research and deep industry knowledge, Verisk helps build global resilience for individuals, communities and businesses. With teams across more than 20 countries, Verisk consistently earns certification by Great Place to Work and fosters an inclusive culture where all team members feel they belong. For more, visit and the Verisk Newsroom

To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Press Release: Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in Immunology7.12.2023 03:30:00 CET | Press release

R&D Day Sanofi Pipeline Transformation to Accelerate Growth Driven by Record Number of Potential Blockbuster Launches, Paving the Way to Industry Leadership in Immunology Details strong pipeline including Sanofi’s record 12 blockbuster opportunities under clinical evaluation: 9 innovative medicines and vaccines with €2 to 5 billion peak sales potential, and 3 ‘pipeline-in-a-product’ assets with a potential of over €5 billion peak sales Strategic transformation through R&D features potential multi-indication assets such as amlitelimab, frexalimab and the oral TNFR1si intended to address unmet patient needs in markets with low penetration of advanced therapiesEnhanced R&D focus aims to deliver a 50% increase in Phase 3 trials in 2024 and 2025 as well as 25 mid- to late-stage read-outs over the next 2 yearsAmbition to become an immunology powerhouse driven by recent and future launched pharma assets, generating over €10 billion in annual sales by 2030, in addition to the strong growth of

Bombardier Completes Redemption for All of its 7.50% Senior Notes due 20256.12.2023 23:01:00 CET | Press release

MONTRÉAL, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has redeemed all of its outstanding US$380 million aggregate principal amount of its 7.50% Senior Notes due 2025 (the “Redemption Notes”), as set forth in the notice of redemption issued November 6, 2023. Payment of the redemption price and surrender of the Redemption Notes for redemption are being made through the facilities of the Depository Trust Company in accordance with their applicable procedures. This press release does not constitute an offer to sell or buy or the solicitation of an offer to buy or sell any security and shall not constitute an offer, solicitation, sale or purchase of any securities in any jurisdiction in which such offering, solicitation, sale or purchase would be unlawful. The securities mentioned herein have not been and will not be registered under the United States Securities Act of 1933, as amended, any state securities laws or the laws of any other jurisdic

CNH Industrial: Periodic Report on $1 Billion Buyback Program6.12.2023 22:30:00 CET | Press release

CNH Industrial: Periodic Report on $1 Billion Buyback Program Basildon, December 6, 2023 CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) announces that under the €400 million component (the “First Component”) of its $1 billion share buyback program the Company completed transactions in the period November 27, 2023 through November 28, 2023, reported in aggregate, as set forth in the table below. After the purchases announced today and considering those previously executed under the First Component, the total invested amount in the First Component is approximately €187,597,638.20 ($203,388,077.50) or a total amount of 20,060,075 common shares purchased. DateNumber of common shares purchasedAverage price per share excluding feesConsideration excluding fees Consideration (*) excluding fees(€)(€)($) November 27,2023 1,500,000 9.3947 14,092,050.00 15,432,203.96 November 28,2023 1,000,000 9.5264 9,526,400.00 10,430,455.36 2,500,000 - 23,618,450.0025,862,659.32 (*) All translations determined fro

Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry6.12.2023 22:00:09 CET | Press release

Believed to be first ever psilocybin clinical trial for treatment of bipolar II depression LONDON, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the publication of a paper in JAMA Psychiatry that demonstrates the potential for investigational COMP360 psilocybin treatment in treatment-resistant bipolar type II disorder (bipolar II). Results from the investigator-initiated open-label study were first presented at the Annual Meeting of the American College of Neuropsychopharmacology in 2022. The study, which was conducted by Dr Scott Aaronson at Sheppard Pratt, Baltimore, and funded by Compass, investigated the safety and efficacy of a single 25mg dose of COMP360 psilocybin treatment in participants with treatment-resistant bipolar II. The primary endpoint was change in Montgomery-Åsberg Depression Rating Scale (MADRS) total s Announces Commitment to Elevate Technology Leadership in Global Sustainability Efforts at COP286.12.2023 20:25:50 CET | Press release

REDWOOD CITY, California, Dec. 06, 2023 (GLOBE NEWSWIRE) --, a leading nonprofit organization championed by technology executives, today affirmed its commitment to advancing global sustainability through information technology innovation and leadership. This announcement comes as a strategic response to the ongoing COP28 United Nations Climate Change Conference, emphasizing the need for a stronger technology presence in sustainability dialogues and decision-making processes. The COP28 event underscores the urgent need for a global conversation on sustainability strategy. However, it also highlights a significant gap: the limited involvement of digital, data, and information technology leaders in these critical discussions. Floor Bleeker, Group Chief Technology Officer of Accor and member of’s European Advisory Board, is one of the technology executives participating in this year's conference. Bleeker will be speaking on a panel with ServiceNow on Dec